Publication | Open Access
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial
76
Citations
23
References
2024
Year
Australian National Health Medical Research Council; Boehringer Ingelheim.
| Year | Citations | |
|---|---|---|
Page 1
Page 1